Pharma fundraising in the digital age: HCS Pharma dives into crypto
Have you thought of fundraising via crypto tokens for your next clinical trial? HCS Pharma is looking to break new…
All articles by Reynald Castañeda
Reynald Castañeda
@pharmarey
Reynald Castañeda is the lead editor of Clinical Trials Arena. Reynald's coverage focuses on outsourcing, partnering, and supply chains. An experienced healthcare journalist, he was previously an associate editor for GlobalData’s Investigative News Team, writing scoops and feature news articles on drug development.
-
-
Clinical trials in Russia: big pharma makes moves but what’s the pipeline impact?
It’s only been a month since the Ukraine war started, yet thousands of lives have been lost, millions have fled…
-
Clinical trials in Russia: drug development pipeline at risk
Due to the ongoing invasion of Ukraine by Russia, many countries have imposed sanctions against Russia and private companies have…
-
Top medical university in Russia pauses clinical trials, sample transport paralysed
Clinical trials sponsored by international pharma companies at the First Moscow State Medical University have paused recruiting new patients, says…
-
Ukraine: Former FDA-er calls for agency to freeze Russian regulatory requests
Former FDA orphan drugs office director Tim Coté is set to file for a citizen petition today to the agency…
-
Pharma developments in 2022: what you need to know
Against the backdrop of the Covid-19 pandemic, pharma and biotech companies continue to innovate not just in the field of…
-
Vaxine to file for Australian approval of protein subunit Covid-19 vaccine
Vaxine is looking to bring its Australia-developed Covid-19 vaccine home. The Adelaide-based company is aiming to file for provisional approval…
-
Can DreamTec turn its bacteria-based oral Covid-19 vaccine into a reality?
With many Covid-19 vaccines authorised and billions of doses already manufactured, second-generation vaccine makers are looking for ways to improve…
-
In conversation: South Africa Covid-19 vaccine expert Shabir Madhi
Snapshot: Lagging vaccination rates and waning immunity from natural infections in South Africa may lead to a fourth wave from…
-
Valneva could outsource Covid-19 vaccine manufacturing in response to demand
Valneva could secure a contract manufacturing organisation (CMO) in Europe if additional capacity is required to manufacture its Covid-19 vaccine,…